๐๐ข๐ฌ๐ข๐จ๐ง ๐๐ฆ๐ฉ๐๐ข๐ซ๐ฆ๐๐ง๐ญ ๐๐ข๐ง๐ค๐๐ ๐ญ๐จ ๐๐ง๐ ๐ข๐ง...
๐๐ข๐๐๐๐ญ๐ข๐ ๐๐ฒ๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐จ๐ง ๐ญ๐ก๐ ๐๐ข๐ฌ๐, ๐๐ฎ๐ญ ๐๐๐ฏ๐๐ซ๐ ๐๐๐ฌ๐๐ฌ ๐๐๐๐ฅ๐ข๐ง๐
๐ Recent research from the Perelman School of Medicine at the University of Pennsylvania reveals a complex landscape for diabetic eye disease in the United States. While the prevalence of diabetes-related retinal conditions has nearly doubled since 2014, the most severe forms of these diseases have notably decreased.
Key Findings:
๐ Prevalence Increase: Between 2014 and 2021, the prevalence of diabetes-related retinal diseases rose from 10.8% to 20.8%.
๐ Incidence Rate Growth: New cases nearly doubled, increasing from 17.7 per 1,000 person-years in 2013 to 32.2 in 2022.
๐ Decline in Severe Cases: Despite overall increases, severe vision-threatening conditions decreased by 10% in prevalence.
๐ Significant Reduction in Proliferative Diabetic Retinopathy: Cases fell by nearly 300%, from 8.3 per 1,000 person-years in 2002 to 2.6 in 2022.
๐ These findings suggest that advancements in diabetes diagnosis and treatment are effectively preventing severe vision loss, even as more individuals develop diabetes-related retinal conditions. Lead researcher Brian VanderBeek, MD, MPH, MSCE, noted that improved insurance coverage and preventive healthcare, such as the Affordable Care Act, have enhanced access to care and screening.
๐ฉโ๐ป The research team plans to explore disparities among racial and ethnic subpopulations and differences between type 1 and type 2 diabetes patients. This future analysis aims to identify at-risk groups and tailor interventions accordingly.
๐ In summary, while the rise in diabetic retinal diseases is concerning, the decline in severe cases offers hope. Continued improvements in healthcare access and diabetes management are crucial to sustaining these positive trends and preventing vision-threatening conditions.
